How microchips could help detect prostate cancer

Google+ Pinterest LinkedIn Tumblr +

Professor Flewitt and academic urological surgeon Mr Vincent Gnanapragasam, who co-leads the CRUK Cambridge Centre Urological Malignancies Programme, are using FBAR sensor technology in a new PSA test.

FBARs are strips on a chip that measure the weight of different molecules. They can be used to measure the amount of different subtypes of PSA in a blood sample to identify more accurately whether or not the patient has prostate cancer – a reliable and cost-effective test, using bio-sensor technology, to be delivered in a primary care setting within the goal of the next five years.

Credit: BBC Richard Westcott YouTube

Share.

About Author

ONA Editor

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.